Valeant Announces Q2 2017 Financial Results Date And Conference Call Details

LAVAL, Quebec, July 10, 2017 /CNW/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it plans to release second quarter 2017 financial results on Tuesday, Aug. 8, 2017. The Company will host a conference call and live webcast at 8:00 a.m. EDT to discuss the results and provide a business update. All materials will be made available on the investor relations portion of the corporate website before the start of the conference call.

Conference Call Details




Tuesday, Aug. 8, 2017


8:00 a.m. EDT


Participant Event Dial-in 

(877) 876-8393 (North America)

(443) 961-0178 (International) 

Participant Passcode


Replay Dial-in

(855) 859-2056 (North America)

(404) 537-3406 (International) 

Replay Passcode

31833 (replay available until Oct. 8, 2017)

About Valeant
Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. More information about Valeant can be found at


Investor Contacts:

Arthur Shannon                                    

Elif McDonald                      



877-281-6642 (toll free)                         

877-281-6642 (toll free) 

Media Contact:  

Lainie Keller   



View original content with multimedia:

SOURCE Valeant Pharmaceuticals International, Inc.

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890